Evaluation of the Efficacy of Platelet-rich Plasma (PRP) on Advanced Endoscopic Resection Techniques

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02931149
• Date of registration: 07/10/2016
• Prospective Registration: No
• Primary sponsor: Germans Trias i Pujol Hospital
• Public title: Evaluation of the Efficacy of Platelet-rich Plasma (PRP) on Advanced Endoscopic Resection Techniques
• Scientific title: Evaluation of the Efficacy of Platelet-rich Plasma (PRP) on Advanced Endoscopic Resection Techniques
• Date of first enrolment: August 2016
• Target sample size: 11
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02931149
• Study type: Interventional
• Study design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
• Phase: Phase 3

Countries of recruitment

Spain

Contacts

• Name: Vicente Lorenzo-Zúñiga García, M.D., Ph.D.
• Affiliation: University Hospital Germans Trias

Key inclusion & exclusion criteria

Inclusion Criteria:

- Endoscopic lesion higher than 40mm in diameter submitted to endoscopic resection (EMR
or eSD)

Exclusion Criteria:

- Ineligibility to endoscopic resection



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Platelet-rich Plasma

Endoscopic Submucosal Dissection

Endoscopic Mucosal Resection

Intervention(s)

Drug: Platelet-rich plasma

Primary Outcome(s)

Prevention of coagulation syndrome (or postpolipectomy syndrome): percentage of participants with coagulation syndrome [Time Frame: 5 days after resection]

Prevention of delayed bleeding: percentage of participants with delayed bleeding [Time Frame: 28 days after resection]

Secondary ID(s)

EndoPRP2016

Source(s) of Monetary Support

Please refer to primary and secondary sponsors